London Daily

Focus on the big picture.
Wednesday, Oct 22, 2025

Russia wants to win the race for the coronavirus vaccine

Russia wants to win the race for the coronavirus vaccine

Moscow researchers say one of the country's possible coronavirus vaccines has proven safe in small-scale human trials and is ready for further testing.
Some might say it's a modest victory for a country that has sought for years to restore the reputation of having cutting-edge science of the Soviet era, and for President Vladimir Putin.

However, on Thursday, Britain, the United States and Canada accused Russia of hacking data from international research centers that are trying to develop a vaccine.

The Kremlin denies any involvement, while the head of the country's sovereign wealth fund called the allegations an attempt to tarnish the Russian investigative effort.

It remains an accusation that jeopardizes the desired drive for prestige inoculation.

Old school vaccine diplomacy could help. Even in the depths of the Cold War, Soviet and American doctors worked collaboratively to combat polio, and later smallpox.

Russia is also not the only nation desperate to find a quick solution, and preferably first.

However, the pressure there is acute. Putin needs to boost his deteriorating popularity, despite the overwhelming approval of a plebiscite this month that approved constitutional changes, which could keep him in power until 2036.

The need has only increased with massive protests in the western city of Khabarovsk, after the local governor's arrest last week.

The covid-19 outbreak has been intense in Russia, which has the fourth highest number of cases worldwide.

Mortality rates have been remarkably low, but new cases continue to rise at a rate of more than 6,000 per day.

The economy has been hit hard. However, efforts to develop a vaccine are as much about regaining a status tarnished by years of low investment, a dramatic exodus of professionals, and last year's accusations of plagiarism and other unethical practices that led to the removal of hundreds of items. academics.

Even before the coronavirus, innovation and science were cornerstones of the $400 billion development plan that Putin hopes to leave as a legacy. Unfortunately, time pressure and patriotism don't always produce the best results.

For now, what we know of Russia's vaccine effort is encouraging.

Sechenov University is testing a vaccine developed by the Gamaleya Institute of Epidemiology and Microbiology in Moscow, and is preparing to discharge its latest volunteers after the initial phase of the study.

He recorded an immune response and found that the prototype was safe. The military, who conducted a parallel study, have made similar comments and released their own volunteers.

Russia is not as advanced as AstraZeneca Plc and the University of Oxford or Chinese researchers, but it has more than a dozen promising vaccine candidates, and Gamaleya is among the favorites, along with prototypes developed by the Vector Institute in Siberia, formerly the Soviet Biological Weapons Research Center.

However, there are still many things that we will not know. The data from the first phase of the Gamaleya trial is not yet public and further testing will be required.

The third and final phase, which tests the vaccine's actual effectiveness in a larger universe, would normally take anywhere from six months to a year.

It is not even clear whether Russia, which is no longer a major exporter of vaccines, can manufacture enough.

However, this has not dampened enthusiasm in the state media or acts of bravery like that of Gamaleya researchers who voluntarily injected themselves with the untested prototype.

Practices such as recruiting volunteers for the Gamaleya study among employees of the state-owned Sberbank PJSC appealing to their patriotism are no less worrisome.

Or simplified methods, as in a vague Moscow study that encouraged doctors to try the antimalarial drug hydroxychloroquine. Piracy charges make matters worse.

If Russia wants to reap the diplomatic and political benefits of a local vaccine, it needs a victory to be credible, at home and abroad.

Following international standards and collaborating would be a start. In fact, Putin may have no choice: Large-scale testing may be required in countries where the infection rate is highest.

It will not yet come naturally to Putin's nationalist administration, which has long struggled to reconcile aspirations for scientific glory with a determination to tighten control.

The Kremlin has tried to monitor contacts with foreign investigators, and several academics with ties abroad have been charged with treason. Other governments will now be more cautious as well.

However, history suggests that it can be done successfully, with the United States and other countries.

Peter Hotez of Baylor College of Medicine, who has served as a scientific envoy to former United States President Barack Obama and who has written extensively on the subject, particularly highlights the cooperation between American physician Albert Sabin and Soviet virologist Mikhail Chumakov on the vaccine. oral against polio in the late 1950s.

Relations had thawed shortly after Josef Stalin's death, but they were still tense and competitive: Sputnik was launched in 1957. Both sides wanted to steal technological secrets.

Still, a few years later, there was collaboration again when Soviet scientists pioneered a freeze-drying technique for the smallpox vaccine.

Unfortunately, the environment today might be too 'toxic'.
Newsletter

Related Articles

0:00
0:00
Close
‘Frightening’ First Night in Prison for Sarkozy: Inmates Riot and Shout ‘Little Nicolas’
White House Announces No Imminent Summit Between Trump and Putin
US and Qatar Warn EU of Trade and Energy Risks from Tough Climate Regulation
Apple Challenges EU Digital Markets Act Crackdown in Landmark Court Battle
Nicolas Sarkozy begins five-year prison term at La Santé in Paris
Japan stocks surge to record as Sanae Takaichi becomes Prime Minister
This Is How the 'Heist of the Century' Was Carried Out at the Louvre in Seven Minutes: France Humiliated as Crown with 2,000 Diamonds Vanishes
China Warns UK of ‘Consequences’ After Delay to London Embassy Approval
France’s Wealthy Shift Billions to Luxembourg and Switzerland Amid Tax and Political Turmoil
"Sniper Position": Observation Post Targeting 'Air Force One' Found Before Trump’s Arrival in Florida
Shouting Match at the White House: 'Trump Cursed, Threw Maps, and Told Zelensky – "Putin Will Destroy You"'
Windows’ Own ‘Siri’ Has Arrived: You Can Now Talk to Your Computer
Thailand and Singapore Investigate Cambodian-Based Prince Group as U.S. and U.K. Sanctions Unfold
‘No Kings’ Protests Inflate Numbers — But History Shows Nations Collapse Without Strong Executive Power
Chinese Tech Giants Halt Stablecoin Launches After Beijing’s Regulatory Intervention
Manhattan Jury Holds BNP Paribas Liable for Enabling Sudanese Government Abuses
Trump Orders Immediate Release of Former Congressman George Santos After Commuting Prison Sentence
S&P Downgrades France’s Credit Rating, Citing Soaring Debt and Political Instability
Ofcom Rules BBC’s Gaza Documentary ‘Materially Misleading’ Over Narrator’s Hamas Ties
Diane Keaton’s Cause of Death Revealed as Pneumonia, Family Confirms
Former Lostprophets Frontman Ian Watkins Stabbed to Death in British Prison
"The Tsunami Is Coming, and It’s Massive": The World’s Richest Man Unveils a New AI Vision
Outsider, Heroine, Trailblazer: Diane Keaton Was Always a Little Strange — and Forever One of a Kind
Dramatic Development in the Death of 'Mango' Founder: Billionaire's Son Suspected of Murder
Two Years of Darkness: The Harrowing Testimonies of Israeli Hostages Emerging From Gaza Captivity
EU Moves to Use Frozen Russian Assets to Buy U.S. Weapons for Ukraine
Europe Emerges as the Biggest Casualty in U.S.-China Rare Earth Rivalry
HSBC Confronts Strategic Crossroads as NAB Seeks Only Retail Arm in Australia Exit
U.S. Chamber Sues Trump Over $100,000 H-1B Visa Fee
Shenzhen Expo Spotlights China’s Quantum Step in Semiconductor Self-Reliance
China Accelerates to the Forefront in Global Nuclear Fusion Race
Yachts, Private Jets, and a Picasso Painting: Exposed as 'One of the Largest Frauds in History'
Australia’s Wedgetail Spies Aid NATO Response as Russian MiGs Breach Estonian Airspace
McGowan Urges Chalmers to Cut Spending Over Tax Hike to Close $20 Billion Budget Gap
Victoria Orders Review of Transgender Prison Placement Amid Safety Concerns for Female Inmates
U.S. Treasury Mobilises New $20 Billion Debt Facility to Stabilise Argentina
French Business Leaders Decry Budget as Macron’s Pro-Enterprise Promise Undermined
Trump Claims Modi Pledged India Would End Russian Oil Imports Amid U.S. Tariff Pressure
Surging AI Startup Valuations Fuel Bubble Concerns Among Top Investors
Australian Punter Archie Wilson Tears Up During Nebraska Press Conference, Sparking Conversation on Male Vulnerability
Australia Confirms U.S. Access to Upgraded Submarine Shipyard Under AUKUS Deal
“Firepower” Promised for Ukraine as NATO Ministers Meet — But U.S. Tomahawks Remain Undecided
Brands Confront New Dilemma as Extremists Adopt Fashion Labels
The Sydney Sweeney and Jeans Storm: “The Outcome Surpassed Our Wildest Dreams”
Erika Kirk Delivers Moving Tribute at White House as Trump Awards Charlie Presidential Medal of Freedom
British Food Influencer ‘Big John’ Detained in Australia After Visa Dispute
ScamBodia: The Chinese Fraud Empire Shielded by Cambodia’s Ruling Elite
French PM Suspends Macron’s Pension Reform Until After 2027 in Bid to Stabilize Government
Orange, Bouygues and Free Make €17 Billion Bid for Drahi’s Altice France Telecom Assets
Dutch Government Seizes Chipmaker After U.S. Presses for Removal of Chinese CEO
×